| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,838 |
7,491 |
$1.67M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,790 |
10,472 |
$654K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,277 |
1,177 |
$357K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,786 |
3,722 |
$287K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
642 |
587 |
$158K |
| 71045 |
Radiologic examination, chest; single view |
4,079 |
3,888 |
$156K |
| 80053 |
Comprehensive metabolic panel |
5,042 |
4,480 |
$123K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,209 |
3,156 |
$102K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,490 |
1,457 |
$78K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,230 |
5,494 |
$72K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,073 |
4,981 |
$63K |
| 87430 |
|
3,315 |
3,268 |
$54K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,833 |
1,628 |
$50K |
| 70450 |
Computed tomography, head or brain; without contrast material |
482 |
454 |
$35K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
722 |
717 |
$32K |
| 81003 |
|
4,690 |
4,416 |
$28K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
514 |
495 |
$22K |
| 83690 |
|
2,374 |
2,164 |
$22K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
291 |
284 |
$14K |
| 87634 |
|
186 |
185 |
$13K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,698 |
2,189 |
$11K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
721 |
716 |
$11K |
| 84484 |
|
1,547 |
1,211 |
$10K |
| 83880 |
|
559 |
511 |
$10K |
| 81025 |
|
881 |
834 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,113 |
712 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
86 |
81 |
$5K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
228 |
222 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
865 |
764 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
970 |
892 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
35 |
33 |
$4K |
| 83605 |
|
436 |
289 |
$3K |
| 84703 |
|
514 |
485 |
$3K |
| 87040 |
|
477 |
234 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
650 |
610 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
393 |
359 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
400 |
365 |
$2K |
| 85730 |
|
512 |
483 |
$2K |
| 85610 |
|
568 |
534 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,596 |
1,392 |
$1K |
| CP007 |
|
31 |
30 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
206 |
189 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$864.51 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
576 |
459 |
$815.53 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
263 |
258 |
$530.96 |
| 87081 |
|
25 |
25 |
$380.15 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
262 |
214 |
$317.92 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
118 |
109 |
$261.87 |
| 81001 |
|
84 |
74 |
$221.12 |
| 96376 |
|
48 |
37 |
$210.14 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
283 |
264 |
$207.71 |
| 85379 |
|
32 |
28 |
$159.87 |
| 86900 |
|
63 |
53 |
$107.06 |
| 86901 |
|
56 |
53 |
$97.46 |
| 83735 |
|
16 |
14 |
$75.32 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
68 |
65 |
$73.27 |
| J7510 |
Prednisolone oral, per 5 mg |
156 |
156 |
$31.05 |
| 94760 |
|
19 |
18 |
$19.39 |
| 36415 |
Collection of venous blood by venipuncture |
1,286 |
1,118 |
$10.72 |
| A9270 |
Non-covered item or service |
2,968 |
2,780 |
$0.00 |